A new study has shown glaucoma patients could be set to benefit from the development of a tiny draining device for the eye.
Results of the HYDRUS I clinical trial, which indicate successful control of eye pressure in all study participants, are being presented at the 116th Annual Meeting of the American Academy of Ophthalmology, jointly conducted this year with the Asia-Pacific Academy of Ophthalmology.
It was noted that the device could help protect millions of glaucoma patients from vision loss or blindness by cutting intraocular pressure (IOP).
Some 69 patients suffering from mild to moderate open-angle glaucoma were tested for the research and IOP was reduced to acceptable levels in 100 per cent of participants after they received minimally invasive stent implant surgery.
A study recently carried out at Robert Wood Johnson Medical School in New Jersey found individuals who have been diagnosed with glaucoma may be able to read better using a digital tablet than a printed book or newspaper.
Find the nearest Barchester nursing home